{"data":{"markdownRemark":{"html":"<p>You might have heard that there was a clinical trial at the Children's Hospital of Philadelphia (CHOP) using the drug baricitinib or (especially if you're outside of the USA) you may have heard about a related drug ruxolitinib. You might have heard that they can put your child's immune system at risk or you might have heard that they haven't been proven to work. I hope that you've heard positive things by now and I would like to help explain where things stand.</p>\n<h1>Mechanism</h1>\n<p>These related drugs </p>\n<h1>Clinical Trials</h1>\n<p>The current clinical trial in the USA runs out of CHOP (<a href=\"https://clinicaltrials.gov/ct2/show/NCT03921554\">https://clinicaltrials.gov/ct2/show/NCT03921554</a>).</p>\n<blockquote>\n<p><a href=\"https://www.research.chop.edu/cornerstone-blog/multi-site-study-builds-better-clinical-trials-for-aicardi-goutieres-syndrome\">Dr. Vanderver emphasizes that the current project is not about testing whether or not baricitinib works. Instead, it focuses on the creation of appropriate assessments and biomarkers for testing the effectiveness of all proposed treatments for AGS.</a></p>\n</blockquote>","frontmatter":{"title":"Parent's Guide to Securing Anti-JAK Treatment","date":"2019-05-07","author":"Patrick Winters"}}},"pageContext":{"slug":"/antiJAKGuide/"}}